Advertisement

Letter to the Editor: Definitive Chemoradiotherapy Versus Trimodality Therapy for Resectable Oesophageal Carcinoma: Meta-analyses and Systematic Review of Literature

  • Han-Yu DengEmail author
Letter to the Editor
  • 10 Downloads

Notes

Compliance with ethical standards

Conflict of interest

None declared.

References

  1. 1.
    Voeten DM, den Bakker CM, Heineman DJ et al (2019) Definitive chemoradiotherapy versus trimodality therapy for resectable oesophageal carcinoma: meta-analyses and systematic review of literature. World J Surg.  https://doi.org/10.1007/s00268-018-04901-z Google Scholar
  2. 2.
    Deng HY, Li G, Luo J et al (2018) Can definitive chemoradiotherapy be an alternative to surgery for early-stage oesophageal cancer? Interact Cardiovasc Thorac Surg 28:37–40CrossRefGoogle Scholar
  3. 3.
    Wang BY, Hung WH, Wu SC et al (2018) Comparison between esophagectomy and definitive chemoradiotherapy in patients with esophageal cancer. Ann Thorac Surg.  https://doi.org/10.1016/j.athoracsur.2018.11.036 Google Scholar
  4. 4.
    NCCN Guidelines for Treatment of Cancer by Site: Esophageal and Esophagogastric Junction Cancers. https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf. Accessed 5 Jan 2018
  5. 5.
    Ma MW, Gao XS, Gu XB et al (2018) The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma World journal of surgical oncology 16:172Google Scholar

Copyright information

© Société Internationale de Chirurgie 2019

Authors and Affiliations

  1. 1.Lung Cancer Center/Department of Thoracic Surgery, West China HospitalSichuan UniversityChengduChina

Personalised recommendations